The race is on for new treatments that stand up to omicron's explosive spread. With omicron's explosive spread threatening to outpace current COVID-19 treatments, the race is on to find new options ...

A research team led by the University of Delaware’s Kelvin Lee is working to change that. Lee, the Gore Professor of Chemical ...

A new study is reviving hope that a twice-daily pill can slow down Alzheimer's in people whose genes put them at high risk ...

In 1975, Georges Köhler and César Milstein, biochemists from the Medical Research Council Laboratory of Molecular Biology, published a paper in Nature about a hybridoma technology that enabled the ...

Vaccines prompt the immune system to produce antibodies that protect against infection and disease. Research published in November shows that, for malaria, giving antibodies to people directly also ...

COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the omicron variant that now accounts for nearly all U.S. infections, U.S. health ...

To develop monoclonal antibody biomanufacturing innovations and produce an anti-filovirus Medical Countermeasure.

Pancreatic cancer is notoriously hard to treat and often resists the most advanced immunotherapies. Northwestern Medicine ...

The pause affects Sotrovimab from GlaxoSmithKline. The federal government is sharply pulling back on one of the monoclonal antibody treatments authorized for COVID-19, pausing its use across eight ...

Southwest Florida's largest hospital operators have run out or are waiting on their first shipments of a type of monoclonal antibody treatment considered to be the most effective against the omicron ...

The Indian Council of Medical Research (ICMR) has invited Expressions of Interest (EoI) for developing and manufacturing ...